Recent Patent Rulings Can Impede the Progress of Personalized Medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

Michael R. Samardzija

Recent Patent Rulings Can Impede the Progress of Personalized Medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

Michael R. Samardzija

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	74
Number of pages	1
Journal	BioPharm International
Volume	22
Issue number	8
State	Published - Aug 2009
Externally published	Yes

ASJC Scopus Subject Areas

Biotechnology
Pharmaceutical Science

Disciplines

Pharmacology
Process Control and Systems

OpenUrl availability

Full text

Cite this

@article{52ff8ae2933649e992869defe5bc7f2d,

title = "Recent Patent Rulings Can Impede the Progress of Personalized Medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable",

author = "Samardzija, \{Michael R.\}",

year = "2009",

month = aug,

language = "American English",

volume = "22",

pages = "74",

journal = "BioPharm International",

issn = "1542-166X",

number = "8",

}

TY - JOUR

T1 - Recent Patent Rulings Can Impede the Progress of Personalized Medicine

T2 - The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

AU - Samardzija, Michael R.

PY - 2009/8

Y1 - 2009/8

UR - https://www.scopus.com/pages/publications/77951636269

UR - https://www.scopus.com/pages/publications/77951636269#tab=citedBy

M3 - Article

SN - 1542-166X

VL - 22

SP - 74

JO - BioPharm International

JF - BioPharm International

IS - 8

ER -

Recent Patent Rulings Can Impede the Progress of Personalized Medicine: The Bilski and Classen decisions can render numerous in vitro diagnostic claims unpatentable

ASJC Scopus Subject Areas

Disciplines

OpenUrl availability

Other files and links

Cite this